Cargando…
Erratum to “Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy” [Sci Pharm. 2013; 81: 843–854]
This is an erratum to the article ‘Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy’ [Sci Pharm. 2013; 81: 843–854]. Figures 1–3 are added.
Autores principales: | Gulati, Neha, Nagaich, Upendra, Saraf, Shubhini A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867247/ https://www.ncbi.nlm.nih.gov/pubmed/24482780 http://dx.doi.org/10.3797/scipharm.1208-18err |
Ejemplares similares
-
Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013) -
Corrigendum to “Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats” [Sci Pharm. 2013; 81: 233–246]
por: Hamden, Khaled, et al.
Publicado: (2014) -
Erratum to “Role of fruit juice in achieving the 5-a-day recommendation for fruit and vegetable intake” Nutrition Reviews 2019;77(11):829–843
Publicado: (2020) -
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
por: Garg, Unnati, et al.
Publicado: (2019) -
Antioxidant and Antibacterial Potential of Silver Nanoparticles: Biogenic Synthesis Utilizing Apple Extract
por: Nagaich, Upendra, et al.
Publicado: (2016)